Login To Trade  |  About IIFL
  • NIFTY  8001.95  53 0.67%
  • SENSEX 26392.38  161.19 0.61%
  1. International

  2. News
  3. News

GIC not to participate in Fortis' preferential funding: report

India Infoline News Service | Mumbai | June 28, 2010 09:22 IST

Fortis promoters was quoted as saying that GIC’s decision to defer investment in their company was “mutual”, as GIC wanted to evaluate the prospects of being part of a larger fund raising plan of Fortis.

Singapore's GIC Special Investments Pte Ltd has reportedly deferred its plan to invest around Rs3.8bn to buy a minority stake in Fortis Healthcare. Fortis promoters was quoted as  saying that GIC’s decision to defer investment in their company was “mutual”, as GIC wanted to evaluate the prospects of being part of a larger fund raising plan of Fortis.


Fortis had, on June 9, taken an enabling resolution to raise up to Rs87.5bn in debt and equity if required. The GIC decision has left Fortis with a shortfall of around Rs4bn in cash, as the amount was expected to come as equity, the report stated.

BSE 173.25 [3.50] ([1.98]%)
NSE 173.20 [3.75] ([2.12]%)

***Note: This is a NSE Chart


Get Top 500 Company Research from acclaimed IIFL Research Team...Click Here!!!

Read more on: GIC  not  to  participate  in  Fortis'  preferential  funding:  repo 
article
113101301269
GIC not to participate in Fortis' preferential funding: report
GIC not to participate in Fortis' preferential funding: report
Fortis promoters was quoted as saying that GIC’s decision to defer investment in their company was “mutual”, as GIC wanted to evaluate the prospects of being part of a larger fund raising plan of Fortis.
http://www.indiainfoline.com/article/news-top-story/gic-not-to-participate-in-fortis-preferential-funding-report-113101301269_1.html
June 28, 2010 09:22 IST
http://content.indiainfoline.com/_media/iifl/img/article/default/glo_news.jpg
GIC not to participate in Fortis' preferential funding: report
News
$rawVideoFileUrl$
$videoPlayerUrl$
News
Recent Reports

Stability in US and Europe to aid export growth

India Infoline Research Team / 10:47, Aug 24, 2015

In spite of massive improvement in CV demand, standalone revenues for Banco Products Ltd registered muted performance with sales at Rs. 113cr in Q1 FY16.